Cargando…

Effects of adenosine receptor agonist on the rocuroniuminduced neuromuscular block and sugammadex-induced recovery

BACKGROUND: Several types of receptors are found at neuromuscular presynaptic membranes. Presynaptic inhibitory A(1) and facilitatory A(2A) receptors mediate different modulatory functions on acetylcholine release. This study investigated whether adenosine A(1) receptor agonist contributes to the fi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Yong Beom, Lee, Sangseok, Choi, Hey Ran, In, Junyong, Chang, Young Jin, Kim, Ha Jung, Ro, Young Jin, Yang, Hong-Seuk
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Anesthesiologists 2018
Materias:	Experimental Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283708/ https://www.ncbi.nlm.nih.gov/pubmed/29690754 http://dx.doi.org/10.4097/kja.d.17.00011

Ejemplares similares

Effects of dexamethasone and hydrocortisone on rocuroniuminduced neuromuscular blockade and reversal by sugammadex in phrenic nerve-hemidiaphragm rat model
por: Choi, Heyran, et al.
Publicado: (2019)

Effects of sevoflurane and adenosine receptor antagonist on the sugammadex‐induced recovery from rocuronium‐induced neuromuscular blockade in rodent phrenic nerve–hemidiaphragm tissue specimens
por: Kim, Yong Beom, et al.
Publicado: (2021)

Effects of different sugammadex doses on the train of four ratio recovery progression during rocuronium induced neuromuscular blockade in the rat phrenic nerve hemidiaphragm
por: Kim, Yong Beom, et al.
Publicado: (2020)

Effects of hydrocortisone-presensitized sugammadex on recovery from neuromuscular blockade induced by rocuronium: a rodent in vivo study
por: Choi, Hey-Ran, et al.
Publicado: (2022)

Chronic exposure to dexamethasone may not affect sugammadex reversal of rocuronium-induced neuromuscular blockade: an in vivo study on rats
por: Park, Ha Yeon, et al.
Publicado: (2023)

Effects of neuromuscular presynaptic muscarinic M(1) receptor blockade on rocuronium‐induced neuromuscular blockade in immobilized tibialis anterior muscles
por: Kim, Yong Beom, et al.
Publicado: (2018)

Effect of protracted dexamethasone exposure and its withdrawal on rocuronium-induced neuromuscular blockade and sugammadex reversal: an ex vivo rat study
por: Oh, Seok Kyeong, et al.
Publicado: (2019)

Effects of presynaptic muscarinic cholinoreceptor blockade on neuromuscular transmission as assessed by the train‐of‐four and the tetanic fade response to rocuronium
por: Kim, Yong Beom, et al.
Publicado: (2017)

The use of sugammadex in an infant with prolonged neuromuscular blockade - A case report -
por: Kim, Hyunho, et al.
Publicado: (2022)

Sugammadex versus neostigmine reversal of moderate rocuronium-induced neuromuscular blockade in Korean patients
por: Woo, Tiffany, et al.
Publicado: (2013)

The combination of sugammadex and neostigmine can reduce the dosage of sugammadex during recovery from the moderate neuromuscular blockade
por: Cheong, Soon Ho, et al.
Publicado: (2015)

Update on the management of neuromuscular block: focus on sugammadex
por: de Boer, Hans D, et al.
Publicado: (2007)

A Meta-Analysis on the Effect of Dexamethasone on the Sugammadex Reversal of Rocuronium-Induced Neuromuscular Block
por: Koo, Chang-Hoon, et al.
Publicado: (2020)

Anesthetic management with a neuromuscular relaxant and sugammadex in a patient with Prader–Willi syndrome: A case report
por: Kim, Kyung Woo, et al.
Publicado: (2020)

Reversal of rocuronium induced neuromuscular blockade using sugammadex in a patient with eclampsia treated by magnesium intraoperatively
por: Song, Sejin, et al.
Publicado: (2014)

The neuromuscular effects of rocuronium under sevoflurane-remifentanil or propofol-remifentanil anesthesia: a randomized clinical comparative study in an Asian population
por: Lee, Sangseok, et al.
Publicado: (2016)

The influence of mild hypothermia on reversal of rocuronium-induced deep neuromuscular block with sugammadex
por: Lee, Hee Jong, et al.
Publicado: (2015)

Sugammadex and Reversal of Neuromuscular Block in Adult Patient with Duchenne Muscular Dystrophy
por: Wefki Abdelgawwad Shousha, Ahmed Abdelgawwad, et al.
Publicado: (2014)

Sugammadex as a reversal agent for neuromuscular block: an evidence-based review
por: Schaller, Stefan Josef, et al.
Publicado: (2013)

Reversal of neuromuscular block with sugammadex in five heart transplant pediatric recipients
por: Carlos, Ricardo Vieira, et al.
Publicado: (2017)

Effects of hyperthermia on the effective concentration of rocuronium and sugammadex-mediated reversal in isolated phrenic nerve hemidiaphragm preparations of rats
por: Kim, Jin Sun, et al.
Publicado: (2020)

Sugammadex: a turning point in our practice
por: Lee, Sangseok
Publicado: (2013)

Sugammadex-induced anaphylactic shock
por: Kim, Ha-Jung, et al.
Publicado: (2020)

Quality of Recovery after Laparoscopic Cholecystectomy Following Neuromuscular Blockade Reversal with Neostigmine or Sugammadex: A Prospective, Randomized, Controlled Trial
por: Han, Jiwon, et al.
Publicado: (2021)

Reversal with sugammadex for rocuronium-induced deep neuromuscular block after pretreatment of magnesium sulfate in rabbits
por: Kang, Woon Seok, et al.
Publicado: (2017)

Rocuronium-induced neuromuscular block and sugammadex in pediatric patient with duchenne muscular dystrophy: A case Report
por: Kim, Ji Eun, et al.
Publicado: (2017)

Reversal of rocuronium‐induced intense neuromuscular blockade by sugammadex in Korean children: A pharmacokinetic and pharmacodynamic analysis
por: Ji, Sang‐Hwan, et al.
Publicado: (2022)

Conventional reversal of rocuronium-induced neuromuscular blockade by sugammadex in Korean children: pharmacokinetics, efficacy, and safety analyses
por: Ji, Sang-Hwan, et al.
Publicado: (2023)

Sugammadex in pediatric patients
por: Choi, Jae Moon, et al.
Publicado: (2022)

In the hour of Sugammadex
por: Chon, Jin Young
Publicado: (2013)

Sensitivity to Rocuronium-Induced Neuromuscular Block and Reversibility with Sugammadex in a Patient with Myotonic Dystrophy
por: Kashiwai, Akihiro, et al.
Publicado: (2012)

Erratum: Factors that affect the onset of action of non-depolarizing neuromuscular blocking agents
por: Kim, Yong Beom, et al.
Publicado: (2017)

Current use of neuromuscular blocking agents and antagonists in Korea: a 2018 survey
por: Kim, Jin Sun, et al.
Publicado: (2019)

The effect of magnesium sulfate concentration on the effective concentration of rocuronium, and sugammadex-mediated reversal, in isolated left phrenic nerve hemi-diaphragm preparations from the rat
por: Cho, Choon-kyu, et al.
Publicado: (2018)

Sugammadex: A revolutionary drug in neuromuscular pharmacology
por: Nag, Kusha, et al.
Publicado: (2013)

Clinical Impact of Sugammadex in the Reversal of Neuromuscular Blockade
por: Goodner, Joshua A, et al.
Publicado: (2021)

Limited advantage of sugammadex reversal over the traditional neuromuscular reversal technique in terms of postoperative recovery of bowel function
por: Kim, Duk Kyung
Publicado: (2020)

Reversal of profound vecuronium-induced neuromuscular block under sevoflurane anesthesia: sugammadex versus neostigmine.
por: Lemmens, Hendrikus JM, et al.
Publicado: (2010)

The effect of magnesium on the reversal of rocuronium-induced neuromuscular block with sugammadex: an ex vivo laboratory study
por: Fábián, Ákos I., et al.
Publicado: (2019)

Effects of sugammadex on the coronary circulation: direct effects on coronary vessels or hypersensitivity (Kounis syndrome)?
por: Yang, Hong-Seuk, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_t70j44ftlfqvgcnn2244iercpu